Prostate specific membrane antigen tumour activated T cell engager therapy(Janux Therapeutics/Merck & Co)

N/A

Report date: 2024/01/26 15:16:23

Base Information

Drug NameProstate specific membrane antigen tumour activated T cell engager therapy(Janux Therapeutics/Merck & Co)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > ImmunoglobulinBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunologic cytotoxicityT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJanux Therapeutics Inc Merck & Co

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A